CDTX
Cidara Therapeutics
CDTX
CDTX
Delisted
CDTX was delisted on the 6th of January, 2026.
173 hedge funds and large institutions have $3.11B invested in Cidara Therapeutics in 2025 Q3 according to their latest regulatory filings, with 77 funds opening new positions, 51 increasing their positions, 30 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
56% more funds holding in top 10
Funds holding in top 10: 9 → 14 (+5)
6.8% more ownership
Funds ownership: 121.35% → 128.16% (+6.8%)
27% less call options, than puts
Call options by funds: $52.4M | Put options by funds: $71.6M
Holders
173
Holding in Top 10
14
Calls
$52.4M
Puts
$71.6M
Top Buyers
| 1 | +$92M | |
| 2 | +$63.9M | |
| 3 | +$60.1M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$51.3M |
| 5 |
BCLSI
Bain Capital Life Sciences Investors
Boston,
Massachusetts
|
+$49.8M |
Top Sellers
| 1 | -$62.2M | |
| 2 | -$56.5M | |
| 3 | -$49M | |
| 4 |
Morgan Stanley
New York
|
-$48.4M |
| 5 |
CM
Caption Management
Oklahoma City,
Oklahoma
|
-$22.8M |
